---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-019112"
form_type: "8-K"
ticker: "STXS"
cik: "0001289340"
company_name: "Stereotaxis, Inc."
filed_at: "2021-08-10T23:59:59+00:00"
generated_at: "2026-06-29T16:18:56.939197+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Stereotaxis Q2 revenue $9.1M (+70% YoY); sees system revenue doubling in 2022

## Summary
- Revenue up ~70% YoY to $9.1M; system revenue $2.7M, recurring $6.1M.
- Operating loss $3.4M, net loss $1.2M; adjusted net income $1.6M excluding stock comp.
- Cash $44.2M; free cash flow negative $0.1M vs negative $1.2M prior year.
- Received two robotic system orders (U.S. and Beijing); expects ~$11M system revenue in 2021.
- Guidance: system revenue doubling in 2022; magnetic ablation catheter regulatory submissions in early 2022.

## SEC filing metadata
- accession: 0001493152-21-019112
- form_type: 8-K
- ticker: STXS
- cik: 0001289340
- company_name: Stereotaxis, Inc.
- filed_at: 2021-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289340/000149315221019112/0001493152-21-019112-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289340/000149315221019112/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-019112
- JSON: https://secwatch.observer/filing/0001493152-21-019112.json
- Plain text: https://secwatch.observer/filing/0001493152-21-019112.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.